Patents by Inventor Mark DEVONALD

Mark DEVONALD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers related to kidney function and methods involving their use
    Patent number: 10761103
    Abstract: The present invention provides a method for diagnosing in a subject Acute Kidney Injury or a related or analogous disease state. The method comprises the steps of a) providing a sample taken from the subject: b) analysing the sample from the subject to determine the level of a biomarker selected from certain atomic species; and c) comparing the level of the biomarker in the sample to a reference level of the biomarker that is characteristic of a healthy subject, eg a subject having normal renal function. An elevated level of the biomarker in the sample relative to the reference level is indicative of Acute Kidney Injury or a related or analogous disease state. The invention also relates to the use of an atomic species selected from those in Table 1 as a biomarker for Acute Kidney Injury or a related or analogous disease state, and test kits comprising an analytical element sensitive to those biomarkers.
    Type: Grant
    Filed: January 7, 2016
    Date of Patent: September 1, 2020
    Assignees: THE UNIVERSITY OF NOTTINGHAM, NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST
    Inventors: Mark Devonald, David Gardner
  • BIOMARKERS RELATED TO KIDNEY FUNCTION AND METHODS INVOLVING THEIR USE
    Publication number: 20180017581
    Abstract: The present invention provides a method for diagnosing in a subject Acute Kidney Injury or a related or analogous disease state. The method comprises the steps of a) providing a sample taken from the subject: b) analysing the sample from the subject to determine the level of a biomarker selected from certain atomic species; and c) comparing the level of the biomarker in the sample to a reference level of the biomarker that is characteristic of a healthy subject, eg a subject having normal renal function. An elevated level of the biomarker in the sample relative to the reference level is indicative of Acute Kidney Injury or a related or analogous disease state. The invention also relates to the use of an atomic species selected from those in Table 1 as a biomarker for Acute Kidney Injury or a related or analogous disease state, and test kits comprising an analytical element sensitive to those biomarkers.
    Type: Application
    Filed: January 7, 2016
    Publication date: January 18, 2018
    Inventors: Mark DEVONALD, David GARDNER